Social Capital Suvretta Holdings Corp. II
Status: Liquidated
U=S
| IPO Proceeds, $M | $250.00M |
|---|---|
| IPO Date | Jun 30, 2021 |
| CEO | Chamath Palihapitiya |
| Left Lead | Morgan Stanley |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector |
Healthcare
Biotechnology industry and within the oncology subsector |
| IPO Geography | Global |
| Target Company | N/A |
| Deal Announced | N/A |
| Deal Size, $M | TBD |
| Deal Sector | TBD |
| Deal Geography | TBD |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | TBD |
| Closing Date | Jul 3, 2023 |
DNAB
| Price | |
|---|---|
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
| Price | |
|---|---|
| Volume, today | |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Social Capital Suvretta Holdings Corp. II:
- Structure and cap table
- 5 directors & officers
- 11 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Chamath Palihapitiya | 44 | CEO & Chairman |
| Kishan (a/k/a Kishen) Mehta | 35 | President & Director |
| James Ryans | 45 | CFO |
| Shoney Katz | 46 | Director of Research |
| Robert Berman | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| Morgan Stanley | BR | 19,800,000 | units |
| SoFi | 2,200,000 | ||
| 22,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee | 3.50 | % |
Sign in to view more advisor data.
Filings
Sign in to view 11 filings.